EU mid-market update: Red across global markets but bond selloff at forefront of damage; Macro focus on US inflation on Wed ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0622 ET – The U.S. Food and Drug Administration’s request for a ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK ... on stocks such as Oxford BioMedica, Zealand Pharma, and Galapagos.

In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal ...

GSK has announced a definitive agreement to acquire IDRx, a US-based biotechnology company specialising in treatments for gastrointestinal cancers, for up to $1.15bn in cash, marking the first ...

Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.

Sales of Apple's iPhone dipped in 2024, with the tech giant losing some of its market share last year, research indicated. Preliminary results from Counterpoint Research's market pulse showed that ...

Sales of Apple's iPhone dipped in 2024, with the tech giant losing some of its market share last year, research indicated. Preliminary results from Counterpoint Research's market pulse showed that ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

GSK (GSK) announced that the US Food and Drug ... syringe presentation of Shingrix for the prevention of shingles. The new prefilled syringe removes the need to reconstitute separate vials prior ...